Access to breast-conserving therapy still an issue for some patients
the ONA take:
According to a new study published in JAMA Surgery, researchers at The University of Texas MD Anderson Cancer Center in Houston, Texas, have found that the rates of breast-conserving therapy for early-stage breast cancer have increased, but access to this treatment modality still remains an issue for some patients.
For the study, researchers analyzed data from approximately 728,000 women with stage T1 or T2 breast cancer treated between 1998 and 2011 from the National Cancer Data Base. Researchers found that the proportion of patients undergoing breast-conserving therapy increased from 54.3% in 1998 to 59.7% in 2006, and leveled off at 60.1% in 2011.
Results showed that certain demographic factors, such as insurance, income, and travel distance to treatment facilities, impact which patients have access to breast-conserving therapy; however, declines in disparities related to age, geographic region, and treatment facility type were also observed.
The findings suggest that the majority of women are opting for breast-conserving therapy, but various disparities still exist that limit access to that treatment approach.
Rates of breast-conserving therapy for early-stage breast cancer have increased.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|